MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

Published: Apr 04, 2012

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America. Ciaran Cooper will be responsible for developing the company’s US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Back to news